
Pharmacally
Type 1 SMA
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Type 1 SMA
ResearchCan Risdiplam Sustain Survival and Motor Function in Children with Type 1 SMA Over 5 Years?Five-year FIREFISH results show that 90% of children with type 1 SMA remained alive and 80% were alive without permanent ventilation after long-term risdiplam treatment, with sustained motor…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.